{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Neither of the provided abstracts addresses the function or role of LINC01514 directly. Abstract"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "focuses on a genomic duplication at 10q24.31–q24.32 that encompasses several genes (including, for instance, BTRC and FBXW4), with the critical region being mapped to exon 1 of BTRC in relation to Split hand/foot malformation type 3. Abstract"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "describes an eight‐lncRNA signature (with an emphasis on genes such as ZFAS1) associated with chemotherapeutic sensitivity in high‐grade serous ovarian cancer. \n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In neither abstract is LINC01514 mentioned or functionally characterized. Thus, based on the provided information, no specific conclusions can be drawn regarding the function of LINC01514.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Catherine F Li, Katie Angione, Jeff M Milunsky "}, {"type": "b", "children": [{"type": "t", "text": "Identification of Critical Region Responsible for Split Hand/Foot Malformation Type 3 (SHFM3) Phenotype through Systematic Review of Literature and Mapping of Breakpoints Using Microarray Data."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Microarrays (Basel) (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/microarrays5010002"}], "href": "https://doi.org/10.3390/microarrays5010002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27600068"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27600068"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Rong Liu, Ying Zeng, Cheng-Fang Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-00050-w"}], "href": "https://doi.org/10.1038/s41598-017-00050-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28154416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28154416"}]}]}]}